Welcome to professional know-how
Get practical videos and helpsheets on pregnancy and baby care, plus all the personalized know-how you need
You already have an account?

Early nutrition

Slower growth and long-term health

Early nutrition

Nutrition plays a vital role both in optimising healthy growth in infants with increasing evidence showing the impact on health later on in life. There are high quality, randomised controlled trials showing the health impact of accelerated growth rates in early years in term infants. Recent research has investigated the links with increased obesity and cardiovascular disease risk.

 

Breastfed infants show an optimum rate of growth and studies show that breastfed infants also have lower levels of various cardiovascular disease risk factors, including:

  • Obesity
  • Dyslipidaemia
  • High blood pressure
  • Insulin resistance

 

Much of this recent research has been carried out by Professors Atul Singhal and Alan Lucas (who specialise in Paediatric Nutrition at the Institute of Child Health, UCL, London)

 

The studies show that faster early postnatal growth adversely impacted on the following problems:

  • Insulin resistance
  • Endothelial dysfunction (an early stage in the atherosclerotic process)
  • Higher blood pressure1

 

This impact is called "programming". Their hypothesis was that postnatal growth acceleration (upward centile crossing) could explain in part adverse programming of effects in term infants and have confirmed an association between faster growth in infancy and later insulin resistance, higher blood pressure and, in 3 systematic reviews, tendency to obesity. ln fact, the adverse long-term effects of faster early growth in human infants appears to be a fundamental biological phenomenon seen across many animal species.

 

The adverse effects of faster growth are seen in both high- and low-income countries, for both weight gain and linear growth. The magnitude of the effect may be substantial.

 

For example, the long-term effect of an optimum rate of growth in the first six months of life may equate to a 3-4 mmHg lowering of diastolic blood pressure. Slower growth rates in early life shown in breastfed children may have a greater impact than conventional public health interventions designed to reduce blood pressure.

 

This is estimated that a slower rate of growth in the early years could prevent over 100,000 cardiovascular events per year in the USA alone.1

 

Formula-fed infants gain weight more quickly than breastfed infants in the first year of life, and this may be due to the greater quantity of protein in infant formulas which are based in cows' milk compared with breast milk.2 A new randomised controlled study has shown that lowering protein levels in infant formula can slow infants' weight gain velocity to a rate that is closer to that of breastfed babies.3

 

Click here to read how this is reflected in SMA First Infant Milk.

 

 

New UK-WHO growth charts

With the introduction of the new WHO Growth charts4 and the adoption of these charts in the UK, focus is on "appropriate" growth of infants. Breastfed infants have a slower rate of growth than formula fed infants. Historically the UK1990 growth charts have plotted a child’s development based on data from predominantly formula fed babies. Using these old charts, healthcare professionals may well have seen breastfed infants who were previously thought to be growing at a slower rate than normal. The new growth UK-WHO charts are now based on predominantly breastfed infants and hence depict a slower rate of growth as being the most appropriate. In addition formula fed infants will now appear to have a faster rate of growth.

 

 

 

References
  1. Singhal A, Lucas A. Early origins of cardiovascular disease. Is there a unifying hypothesis? Lancet 2004; 363: 1642-5.
  2. Koletzko B et al. Lower protein in infant formula is associated with lower weight up to 2 y: a randomised clinical trial. Am J Clin Nutr 2009; 89:1836–45
  3. Trabulsi J. Effect of two different protein concentrations in infant formula on growth and safety in healthy term infants. JPGN 2009; 48(Suppl. 3): E78, PN 1–12
  4. www.rcpch.ac.uk/Research/UK-WHO-Growth-Charts
  1. Singhal A, Lucas A. Early origins of cardiovascular disease. Is there a unifying hypothesis? Lancet 2004; 363: 1642-5.
  2. Koletzko B et al. Lower protein in infant formula is associated with lower weight up to 2 y: a randomised clinical trial. Am J Clin Nutr 2009; 89:1836–45
  3. Trabulsi J. Effect of two different protein concentrations in infant formula on growth and safety in healthy term infants. JPGN 2009; 48(Suppl. 3): E78, PN 1–12
  4. www.rcpch.ac.uk/Research/UK-WHO-Growth-Charts

 Rate
Educational study days

The SMA Nutrition study day programmes are chaired and presented by leading healthcare professionals who are all experts in their fields.


They offer thought-provoking sessions designed to increase the knowledge and expertise of healthcare professionals, and to develop day-to-day professional skills.

Register now for regular updates
  • Unbranded helpsheets in 7 languages
  • Free downloadable literature and tools
  • Access to e-learning modules for professional development
  • Quarterly clinical updates
  • Be the first to hear about our educational study days

SMA products
SMA has 3 different ranges - Core, Specialist and Preterm - designed to meet different babies` nutritional needs. For more information, please click here